Jump to section
To solve the Evidence Gap that has hampered effective clinical decision-making.
Few candidates hear
back within 2 weeks
Spun out from a project developed at Stanford University, Atropos Health was founded to improve the use of generative AI in medical and research decision-making. The company’s software offers on-demand evidence and real-world data to improve evidence collation, elevating clinical trial outcomes.
The use of generative AI for medical purposes is in an exciting place at the moment, and Atropos Health is at the forefront of its evolution. The company’s Geneva Operating System is an original AI system and natural language processor that makes publication-quality clinical data accessible to those without technical skills, and at low cost.
Impressively, the company claims to provide query results in minutes rather than the traditional timeline of 2 to 6 months, hugely speeding up the research process. The power of its operating system is backed by the company’s substantial funding rounds, which will be used to expand operations and grow its portfolio of gen-AI products.
Freddie
Company Specialist at Welcome to the Jungle
May 2024
$33m
SERIES B
Aug 2022
$14m
SERIES A
This company has top investors
Brigham Hyde
(Co-Founder & CEO)Currently a Venture Partner at Audere Capital. Previously a Special Advisor at EVERSANA, was an Official Member of Forbes Technology Council, and worked as a Research Affiliate at MIT.
Nigam Shah
(Co-Founder)Currently Chief Data Scientist at Stanford Health Care, as well as Head of Medicine at Stanford University School of Medicine. Previously interned in Research at IBM.
Saurabh Gombar
(Co-Founder &Chief Medical Officer)Currently Clinical Instructor at Stanford Health Care. Previously studied a PhD at Albert Einstein College of Medicine, founded Alpha Abacus and was a Software Engineer at Ericsson.
Software Engineering